Nerium Biotechnology Stock
Nerium Biotechnology engages in the development of oleander-based products for the treatment of proliferative diseases and viral infections.
Sign up today and learn more about Nerium Biotechnology Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Nerium Biotechnology Stock
Nerium Biotechnology, Inc., a biotechnology company, engages in the development of oleander-based products for the treatment of certain forms of proliferative diseases and viral infections. Its lead product includes Anvirzel, which is used to treat various forms of cancer. The company’s product line also comprises HIviral for the treatment of HIV/AIDS; HEP-viral for the treatment of hepatitis C; and NeriumAD, a skin cream for age-defying treatment. Nerium Biotechnology, Inc. is based in San Antonio, the United States.
Funding History
| March 2011 | $289K |
|---|
Management
Director
John F. O'Donnell
CEO & Chairman of the Board of Directors
Dennis Ray Knocke
CFO
Joseph B. Nester
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
